Esperion Therapeutics
ESPR
#6990
Rank
$0.43 B
Marketcap
$2.19
Share price
0.69%
Change (1 day)
-7.20%
Change (1 year)

Revenue for Esperion Therapeutics (ESPR)

Revenue in 2024 (TTM): $0.29 Billion USD

According to Esperion Therapeutics's latest financial reports the company's current revenue (TTM ) is $0.29 Billion USD. In 2023 the company made a revenue of $0.11 Billion USD an increase over the revenue in the year 2022 that were of $75.47 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Esperion Therapeutics from 2000 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $0.29 B153.97%
2023 $0.11 B54.14%
2022 $75.47 M-3.79%
2021 $78.44 M-65.52%
2020 $0.22 B53.37%
2019 $0.14 B
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2000 $0 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$0.52 B 76.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.75 B 831.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$60.11 B 20,245.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.84 B 4,586.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.49 B 67.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.22 M-98.23%๐Ÿ‡บ๐Ÿ‡ธ USA